Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients

Biocept presents data showing its Target Selector molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS).

MedAI Releases Drug Formulation Development Service for the Pharmaceutical Industry

Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers

PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company

Whole Genome Sequencing for GutFlora Now Available by the GutFlora Omics Platform

The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.

Solentim expands global reach, opening new operation in China

Solentim, the trusted global leader in cell therapy workflows enabling the creation, isolation and characterization of high value cells, announces the opening of a new office in Shanghai. Solentim China is a joint venture with its longstanding distribution partner Trio Biotech Co, and will enhance support for customers and expand commercial activity across the region.

Optibrium appoints Dr Rae Lawrence as Director of Software Development

New role will drive development of AI-based drug discovery software solutions and lead development team expansion

Pronalyse Division Supports Biopharma Research with Protein Homogeneity Analysis Service

Pronalyse, a new division of Creative Proteomics, is dedicated to providing professional analysis services in biopharmaceutical development. Creative Proteomics is an integrated CRO company with more than 10 years of experience in providing impurity analysis and analytical characterization service for bioprocess development. Recently, the product manager of Pronalyse division announced protein homogeneity analysis service to speed up the drug development process.

VERICHEM LABORATORIES EXPANDS REPORT OPTIONS FOR ITS FREE CLIA COMPLIANT CALIBRATION VERIFICATION PROGRAM

VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.

Scytek Laboratories Inc Stain Nuclei Histology Red Special Stain,Histology,Nuclear Fast Red Solution,H E,Eosin

Scytek laboratories offers special Stain, Antibodies, Hematology, Microbiology, Hematoxlyn, Nuclei Histology Red Special Stain, Histology ,Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek

eClinical Solutions Launches elluminate® Clinical Trial Management System (CTMS) for Faster Drug Development

This announcement is in response to the growing need in the industry for solutions like elluminate CTMS that can automate operational data pipelines and reduce the time spent on manual data tracking processes to accelerate clinical development. ​ ​

Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen

Kyruus Announces Significant Core Business Momentum in 2020 as it Accelerates Expansion into the Health Plan Market with Recent Acquisition

IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange (DLX™) platform with Polar™, IDBS’ Biopharmaceutical Lifecycle Management (BPLM) platform

THREAD and 1nHealth Partner to Optimize Participant Recruitment in Decentralized Clinical Trials

Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials

Dotmatics collaborates with HighRes Biosolutions to provide single software interface for lab digitalization

Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN

BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Antibiotic Research UK calls for clear guidance to ensure people on antibiotics do not miss out on the COVID-19 vaccine

Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination.

MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS

MMS Holdings – an award-winning, data-focused CRO – joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance (DTRA),” which launched on December 10th, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research.

Baltimore Aircoil Company Announces HXV Hybrid Cooler